These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 27167388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X, Cojocaru V, Wade RC.
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [Abstract] [Full Text] [Related]

  • 4. Crystal Structure of Cytochrome P450 (CYP105P2) from Streptomyces peucetius and Its Conformational Changes in Response to Substrate Binding.
    Lee CW, Lee JH, Rimal H, Park H, Lee JH, Oh TJ.
    Int J Mol Sci; 2016 May 25; 17(6):. PubMed ID: 27231902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. What Your Crystal Structure Will Not Tell You about Enzyme Function.
    Pochapsky TC, Pochapsky SS.
    Acc Chem Res; 2019 May 21; 52(5):1409-1418. PubMed ID: 31034199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ligand Access Channels in Cytochrome P450 Enzymes: A Review.
    Urban P, Lautier T, Pompon D, Truan G.
    Int J Mol Sci; 2018 May 30; 19(6):. PubMed ID: 29848998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular Dynamics Simulations of a Cytochrome P450 from Tepidiphilus thermophilus (P450-TT) Reveal How Its Substrate-Binding Channel Opens.
    Faponle AS, Roy A, Adelegan AA, Gauld JW.
    Molecules; 2021 Jun 12; 26(12):. PubMed ID: 34204747
    [Abstract] [Full Text] [Related]

  • 12. A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment.
    Fischer A, Smieško M.
    Int J Mol Sci; 2021 Dec 08; 22(24):. PubMed ID: 34948012
    [Abstract] [Full Text] [Related]

  • 13. Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
    Basudhar D, Madrona Y, Kandel S, Lampe JN, Nishida CR, de Montellano PR.
    J Biol Chem; 2015 Apr 17; 290(16):10000-17. PubMed ID: 25670859
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations.
    Karthikeyan BS, Suvaithenamudhan S, Akbarsha MA, Parthasarathy S.
    Cell Biochem Biophys; 2018 Jun 17; 76(1-2):91-110. PubMed ID: 28353142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identifying cytochrome p450 functional networks and their allosteric regulatory elements.
    Liu J, Tawa GJ, Wallqvist A.
    PLoS One; 2013 Jun 17; 8(12):e81980. PubMed ID: 24312617
    [Abstract] [Full Text] [Related]

  • 17. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.
    Martiny VY, Carbonell P, Chevillard F, Moroy G, Nicot AB, Vayer P, Villoutreix BO, Miteva MA.
    Bioinformatics; 2015 Dec 15; 31(24):3930-7. PubMed ID: 26315915
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome P450 2B4.
    Han SB, Teuffel J, Mukherjee G, Wade RC.
    Protein Sci; 2024 Oct 15; 33(10):e5165. PubMed ID: 39291728
    [Abstract] [Full Text] [Related]

  • 20. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle.
    Yoon MY, Campbell AP, Atkins WM.
    Drug Metab Rev; 2004 May 15; 36(2):219-30. PubMed ID: 15237852
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.